Underscoring its potential utility in disease monitoring and personalized medicine, we used Bio-SCOPE to detect upregulation of specific miRNAs in prostate cancer samples, as well as elevated levels of cancer-related miRNA hsa-miR-2132,33 and pro-inflammatory cytokine IL-6 in CAR-T cell therapy patients with CRS47, providing insights into disease mechanisms and therapeutic responses. The gene discussed is IL6; the disease is prostate carcinoma.